Michael Stokes

950 total citations
30 papers, 646 citations indexed

About

Michael Stokes is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics and Surgery. According to data from OpenAlex, Michael Stokes has authored 30 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 6 papers in Economics and Econometrics and 5 papers in Surgery. Recurrent topics in Michael Stokes's work include Atrial Fibrillation Management and Outcomes (5 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Eosinophilic Disorders and Syndromes (4 papers). Michael Stokes is often cited by papers focused on Atrial Fibrillation Management and Outcomes (5 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Eosinophilic Disorders and Syndromes (4 papers). Michael Stokes collaborates with scholars based in United States, United Kingdom and Germany. Michael Stokes's co-authors include Peter J. Goadsby, Teresa K. Wilcox, Andrew Blumenfeld, Richard B. Lipton, Dawn C. Buse, Sepideh F. Varon, Julio Pascual, Paolo Martelletti, Pietro Cortelli and Lisa Bloudek and has published in prestigious journals such as Blood, Journal of the American College of Cardiology and Plastic & Reconstructive Surgery.

In The Last Decade

Michael Stokes

24 papers receiving 605 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Stokes United States 10 404 249 136 74 66 30 646
Megan Smith United States 13 152 0.4× 354 1.4× 64 0.5× 31 0.4× 22 0.3× 27 692
Sally Mannix United States 17 329 0.8× 83 0.3× 48 0.4× 21 0.3× 39 0.6× 33 731
Pooja Desai United States 17 521 1.3× 275 1.1× 164 1.2× 33 0.4× 65 1.0× 45 823
Zafer Güney Türkiye 7 121 0.3× 126 0.5× 53 0.4× 21 0.3× 12 0.2× 21 437
Marie C. Martin United States 8 119 0.3× 60 0.2× 52 0.4× 19 0.3× 38 0.6× 14 515
Changli Zhou China 13 81 0.2× 34 0.1× 128 0.9× 66 0.9× 61 0.9× 24 668
W. Rodríguez United States 11 219 0.5× 121 0.5× 36 0.3× 17 0.2× 22 0.3× 16 679
Denis Simard Canada 13 163 0.4× 98 0.4× 92 0.7× 428 5.8× 98 1.5× 64 1.1k
Maggie Hehir United Kingdom 8 207 0.5× 154 0.6× 43 0.3× 18 0.2× 42 0.6× 11 950

Countries citing papers authored by Michael Stokes

Since Specialization
Citations

This map shows the geographic impact of Michael Stokes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Stokes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Stokes more than expected).

Fields of papers citing papers by Michael Stokes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Stokes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Stokes. The network helps show where Michael Stokes may publish in the future.

Co-authorship network of co-authors of Michael Stokes

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Stokes. A scholar is included among the top collaborators of Michael Stokes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Stokes. Michael Stokes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jackson, David J., et al.. (2025). Systematic Literature Review of Real-World Outcomes of Benralizumab in Eosinophilic Granulomatosis With Polyangiitis. The Journal of Allergy and Clinical Immunology In Practice. 13(11). 3054–3065.e4.
3.
Agarwal, Sanjay K., et al.. (2024). Uterine fibroids with heavy menstrual bleeding stratified by race in a commercial and Medicaid database. AJOG Global Reports. 4(4). 100412–100412.
5.
Tolaney, Sara M., Kevin Punie, Lisa A. Carey, et al.. (2024). Real-world treatment patterns and outcomes in patients with HR+/HER2− metastatic breast cancer treated with chemotherapy in the United States. ESMO Open. 9(9). 103691–103691. 6 indexed citations
6.
Kielar, Danuta, et al.. (2023). Real-World Investigation of Eosinophilic-Associated Disease Overlap (REVEAL): Analysis of a US Claims Database. Allergy Asthma and Immunology Research. 15(5). 580–580. 3 indexed citations
7.
Agarwal, Sanjay K., et al.. (2023). Describing the Patient Journey of Women with Claims for Uterine Fibroids and Heavy Menstrual Bleeding Using a Commercial Database (2011–2020). International Journal of Women s Health. Volume 15. 1561–1575. 5 indexed citations
8.
Tsang, Yuen, et al.. (2023). Impact of selexipag use within 12 months of pulmonary arterial hypertension diagnosis on hospitalizations and medical costs: A retrospective cohort study. The Clinical Respiratory Journal. 17(12). 1209–1222. 3 indexed citations
9.
Stokes, Michael, et al.. (2017). Impact of pharmacy channel on adherence to oral oncolytics. BMC Health Services Research. 17(1). 414–414. 8 indexed citations
10.
Naccarelli, Gerald V., et al.. (2015). Abstract 301: Healthcare Costs Following Stroke and Major Bleeding Events in Nonvalvular Atrial Fibrillation Patients. Circulation Cardiovascular Quality and Outcomes. 8(suppl_2). 3 indexed citations
11.
Hultman, C. Scott, John Y. S. Kim, Anne Taylor, et al.. (2015). The Changing Demographics and Needs of Employed Versus Private Practice Plastic Surgeons. Plastic & Reconstructive Surgery. 136. 61–61. 1 indexed citations
12.
Amin, Alpesh, Michael Stokes, Dinara Makenbaeva, et al.. (2014). MEDICAL COSTS AVOIDED FOR PREVENTION OF STROKE WITH USE OF NOACS: ESTIMATES FOR THE REAL-WORLD. Journal of the American College of Cardiology. 63(12). A330–A330. 1 indexed citations
13.
Amin, Alpesh, Michael Stokes, Dinara Makenbaeva, et al.. (2014). Estimated medical cost reductions associated with use of novel oral anticoagulants vs warfarin in a real-world non-valvular atrial fibrillation patient population. Journal of Medical Economics. 17(11). 771–781. 11 indexed citations
14.
Chen, Shih‐Yin, et al.. (2013). Clinical and economic outcomes among hospitalized patients with acute coronary syndrome: an analysis of a national representative Medicare population. ClinicoEconomics and Outcomes Research. 5. 181–181. 15 indexed citations
15.
Bloudek, Lisa, Michael Stokes, Dawn C. Buse, et al.. (2012). Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS). The Journal of Headache and Pain. 13(5). 361–378. 242 indexed citations
16.
Chen, Shih‐Yin, Kimberly Siu, Birgit Kovacs, et al.. (2012). Clinical and economic outcomes associated with National Kidney Foundation guideline-concordant oral antidiabetic drug treatment among type 2 diabetes patients with chronic kidney disease. Current Medical Research and Opinion. 28(4). 493–501. 13 indexed citations
17.
Stokes, Michael. (2011). Legal Issues arising from the Pulp Mill Permit issued under the Pulp Mill Assessment Act 2007 (Tasmania). eCite Digital Repository (University of Tasmania). 1 indexed citations
18.
Stokes, Michael, Werner J. Becker, Richard B. Lipton, et al.. (2011). Cost of Health Care Among Patients With Chronic and Episodic Migraine in Canada and the USA: Results From the International Burden of Migraine Study (IBMS). Headache The Journal of Head and Face Pain. 51(7). 1058–1077. 190 indexed citations
20.
Stokes, Michael. (1994). Formalism, Realism, and the Concept of Law. Law and Philosophy. 13(2). 115–115.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026